Latest Amines Stories
A meta-analysis of published and unpublished clinical trial data, which was published in the journal PLOS ONE on Aug.
WOODCLIFF LAKE, N.J., Sept. 30, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc.
Additional Study Focuses on the Detection and Quantitative Monitoring of EGFR Mutations in Lung Cancer Patients SAN DIEGO, Sept.
- LUX-Lung 8 trial met its primary endpoint of improving progression-free survival in patients treated with afatinib versus erlotinib after failure of first-line, platinum-based chemotherapy, reducing
DUBLIN, September 22, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/lnlrtk/global_and ) has announced the addition of the "Global
Methadone has been used to treat opiate addiction in America for about 50 years, since Dr. Vincent Dole of New York’s Rockefeller University first discovered that the drug was able to relieve opiate withdrawal symptoms and allow addicts to return to their normal lives.
ReportsnReports.com adds "Market Research Report on Global and Chinese Oxybutynin Hydrochloride (CAS 1508-65-2) Industry, 2009-2019" to its store. DALLAS, Sept.
MONMOUTH JUNCTION, N.J., Sept. 15, 2014 /PRNewswire/ -- Vernalis plc (LSE: VER) and Tris Pharma, Inc. ("Tris") are pleased to announce that the U.S.
Key Step Accomplished Signals the Initiation of Clinical Development for Potential Blockbuster d-methadone NEW YORK, Sept. 10, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
Material Progress on All Fronts in 2014 Leave Company Strongly Positioned to Unlock the Value of its Robust Pain Product Pipeline NEW YORK, Sept.
- totally perplexed and mixed up.